Balyasny Asset Management L.P. Makes New $2.56 Million Investment in Haleon plc (NYSE:HLN)

Balyasny Asset Management L.P. acquired a new position in shares of Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 267,867 shares of the company's stock, valued at approximately $2,555,000.

Several other institutional investors also recently bought and sold shares of HLN. Procyon Advisors LLC boosted its stake in shares of Haleon by 41.3% in the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company's stock valued at $2,196,000 after purchasing an additional 67,329 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Haleon by 29.8% in the fourth quarter. Bank of New York Mellon Corp now owns 2,071,017 shares of the company's stock valued at $19,758,000 after purchasing an additional 475,934 shares during the period. SeaCrest Wealth Management LLC purchased a new position in shares of Haleon in the fourth quarter valued at $102,000. Atria Wealth Solutions Inc. boosted its stake in shares of Haleon by 6.1% in the fourth quarter. Atria Wealth Solutions Inc. now owns 47,868 shares of the company's stock valued at $457,000 after purchasing an additional 2,758 shares during the period. Finally, Janney Montgomery Scott LLC boosted its stake in shares of Haleon by 13.3% in the fourth quarter. Janney Montgomery Scott LLC now owns 850,563 shares of the company's stock valued at $8,114,000 after purchasing an additional 99,666 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HLN has been the subject of several analyst reports. HSBC restated a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Barclays reaffirmed an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Finally, Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Haleon has a consensus rating of "Moderate Buy" and a consensus price target of $11.25.

Haleon Trading Down 0.3%

HLN opened at $10.71 on Tuesday. The stock has a market capitalization of $48.28 billion, a PE ratio of 31.49, a P/E/G ratio of 2.82 and a beta of 0.24. The firm's fifty day moving average price is $10.21 and its 200 day moving average price is $9.84. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a 12-month low of $8.24 and a 12-month high of $10.85.

Haleon (NYSE:HLN - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion for the quarter, compared to analysts' expectations of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, research analysts expect that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The firm also recently announced a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This represents a dividend yield of 1.6%. This is a boost from Haleon's previous -- dividend of $0.05. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.